Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 5 days ago

      Pharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. Although biosimilars will sell at a list price lower than ...

    • Two Is Better Than One in the Alzheimer’s Market

      Two Is Better Than One in the Alzheimer’s Market

      The Wall Street Journal via Yahoo Finance· 5 days ago

      At this point, getting two drugs with moderate benefits out into the market has other advantages for the broader field as well. As these drugs start to...

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 2 days ago

      SHARE YOUR THOUGHTS Are you including GLP-1 drugs in your portfolio? Why or why not? Join the conversation below. Eventually, it stands to reason that...